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Biomimetic mineralization of metal-organic
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biomacromolecules
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Enhancing the robustness of functional biomacromolecules is a critical challenge in
biotechnology, which if addressed would enhance their use in pharmaceuticals,
chemical processing and biostorage. Here we report a novel method, inspired by natural
biomineralization processes, which provides unprecedented protection of biomacromolecules
by encapsulating them within a class of porous materials termed metal-organic frameworks.
We show that proteins, enzymes and DNA rapidly induce the formation of protective
metal-organic framework coatings under physiological conditions by concentrating the
framework building blocks and facilitating crystallization around the biomacromolecules.
The resulting biocomposite is stable under conditions that would normally decompose many
biological macromolecules. For example, urease and horseradish peroxidase protected within
a metal-organic framework shell are found to retain bioactivity after being treated at
80 C and boiled in dimethylformamide (153 C), respectively. This rapid, low-cost
biomimetic mineralization process gives rise to new possibilities for the exploitation of
biomacromolecules.
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M
any living organisms fabricate molecular architectures
speciﬁcally designed to provide exoskeletal protection
and structural support for soft tissue1. This biologically
induced, self-assembly process, termed biomineralization,
is carried out with exquisite control of crystal morphology and
compositional speciﬁcity under physiological conditions2.
Furthermore, the resultant biocomposites typically exhibit
superior mechanical properties with respect to their
constituents3. Accordingly, such natural biomineralization
processes have inspired ‘biomimetic’4 strategies for the synthesis
of novel materials for photonics, biomedical implants, drug
delivery and biochemical separations5–8.
A goal of biomimetic mineralization is to adopt and translate
the self-assembly processes found in natural biological systems to
the development of a general method for encapsulating bioactive
molecules within protective exteriors9. Success in this endeavour
would signiﬁcantly increase the potential for utilizing functional
biomacromolecules in applications where enhanced thermal
stability, tolerance to organic solvents or extended shelf-lifetime
is required, such as industrial catalysis and biopharmaceutical
delivery10–12. To this end, recent studies have demonstrated that
coating bioactive macromolecules with inorganic shells (for
example, calcium phosphate, CaP) can provide prolonged shelf-
lifetime9. Although this report clearly demonstrates the potential
applications of exploiting biomineral shells, seeding an inorganic
architecture at an organic interface presents a signiﬁcant
challenge. Indeed, to stimulate growth of a CaP shell on
vaccines, genetic modiﬁcation was required to incorporate a
speciﬁc peptide sequence known to have a high afﬁnity for
calcium ions9. This result highlights that enhancing the interfacial
interactions between inorganic and organic components is a key
to inducing biomineralization13. However, given that the tertiary
structure of many biomacromolecules is critical to their function,
it is unlikely that a strategy that involves modifying
the primary peptide sequence could be generally applied. We
posit that hybrid organic–inorganic materials would provide a
more versatile and general method for encapsulating
biomacromolecules as, in general, the protein domains have a
high afﬁnity for the organic moieties14. A rapidly growing class of
hybrid materials termed metal-organic frameworks (MOFs)
represent excellent candidates for this purpose, as they are:
constructed from organic and inorganic components15, thermally
and chemically stable16–19, can be grown on different substrates
(ﬁlms20, particles21 and gels22), and under mild biocompatible
conditions19. In addition, they have been utilized as a
biocompatible material for drug release19,23. Furthermore, MOFs
possess open architectures and large pore volumes24, which can
facilitate the selective transport of small molecules through the
protective porous coating25,26, enabling the selective interaction of
the biomacromolecule (for example, enzymes) with the external
environment. Hitherto, attempts to integrate biomacromolecules
within MOFs have been limited in application by two main
constraints: for post-synthetic inﬁltration only biomacromolecules
analogous in size to the MOF pores can be loaded into the
framework27–29, and in the preparation of MOF biocomposites
only solvent resistant biomacromolecules can be used30.
Overcoming these limitations would facilitate the fabrication of
novel biocomposites and their exploitation for bioapplications31.
Here we report that a wide range of biomacromolecules
including proteins, DNA and enzymes can efﬁciently induce
MOF formation and control the morphology of the resultant
porous crystal via a biomimetic mineralization process under
physiological conditions. Although biomineralization has been
extensively investigated for inorganic systems, the concept has
not been applied to MOFs. Here we demonstrate that the
biomimetic mineralization of MOFs forms a nanoporous shell,
which encapsulates the biomacromolecules and affords unprece-
dented protection from biological, thermal and chemical
degradation with maintenance of bioactivity (Fig. 1). Further-
more, the encapsulated biomacromolecules can be released
simply by a pH change within a physiological environment.
Zeolitic imidazolate framework-8 (ZIF-8), formed by coordina-
tion between Zn2þ ions and 2-methylimidazole (HmIm)32, is
selected as a candidate MOF material for this study due to its high
surface area, exceptional chemical and thermal stability and
negligible cytotoxicity23,32,33. In addition, we demonstrate that
other MOFs (HKUST-1, Eu/Tb-BDC and MIL-88A) can also be
formed, highlighting the versatility of this biomimetic
mineralization approach.
Results
Biomimetic mineralization using bovine serum albumin. In a
typical experiment for the biomimetically mineralized growth of
ZIF-8, an aqueous solution containing HmIm, (160mM, 2ml)
and bovine serum albumin (BSA, 1mg) were mixed with a
separate aqueous solution of zinc acetate (40mM, 2ml) at room
temperature. The solution instantaneously turned from trans-
parent to opaque (within 1 s, Supplementary Fig. 1). After cen-
trifugation and washing, truncated cubic crystals of ZIF-8,
(B1mm) were found by scanning electron microscope (SEM;
Fig. 2a) and powder X-ray diffraction (PXRD) measurements
(Fig. 2d, Supplementary Methods). To ascertain that BSA is
indeed encapsulated by a ZIF-8 crystalline shell, solutions of
biomimetically mineralized ZIF-8 that had been washed with a
surfactant to remove any surface bound proteins were examined
by Fourier transform infrared spectroscopy (FTIR). The resulting
spectra showed stretches characteristic of the BSA protein at
B1,640–1,660 and 1,510–1,560 cm 1, corresponding to amide I
(mainly from C¼O stretching mode) and II band (mainly from a
combination between of NH bending and CN stretching modes),
respectively34. However, FTIR measurements collected from
samples prepared by washing a solution containing a mixture
of pre-formed ZIF-8 crystals and BSA protein with surfactant did
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Figure 1 | Schematic illustration of biomimetically mineralized MOF.
(a) Schematic of a sea urchin; a hard porous protective shell that is
biomineralized by soft biological tissue (b) Schematic of a MOF
biocomposite showing a biomacromolecule (for example, protein, enzyme
or DNA), encapsulated within the porous, crystalline shell.
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not afford stretches attributable to BSA (Fig. 2e). These data
clearly demonstrate that the mechanism of BSA encapsulation is
not via absorption nor adsorption through the ZIF-8 pore
network. Additional evidence of biomacromolecule encapsulation
was garnered by using BSA tagged with ﬂuorescein isothiocyanate
(FITC) to induce the formation of ZIF-8. The resultant
biocomposite was washed with surfactant and exposed to
ultraviolet light, whereon a green emission at 521 nm
characteristic of FITC was observed (Fig. 2b). Furthermore,
confocal microscopy revealed that the cross-sections of ZIF-8/
BSA crystals were homogenously luminescent (Fig. 2c, details in
Supplementary Figs 2 and 3). In contrast, crystals isolated from a
mixture of pre-formed ZIF-8 and FITC-labelled BSA were not
emissive (Supplementary Fig. 4).
Physical characterization of the ZIF-8/BSA biocomposite. To
assess the permanent porosity of the ZIF-8/BSA biocomposite, a
77 K nitrogen adsorption isotherm was measured (Supplementary
Figs 5 and 6). The resulting isotherm is best described as Type 1
in shape and BET analysis of the data afforded a surface area of
1,381m2 g 1, showing a decrease of porosity relative to pure
ZIF-8 crystals32, which is consistent with the presence of BSA. To
further investigate the hierarchical pore structure of the ZIF-8/
BSA biocomposite, small-angle X-ray scattering experiments
(SAXS) were carried out. Analysis of the data indicates the
presence of mesopores within the MOF with a radius of
3.5±0.5 nm (Fig. 2f). We note that such mesopores, which are
of sufﬁcient size to accommodate the biomolecule (Fig. 2f, inset),
are not detected in pure ZIF-8 (Supplementary Fig. 7).
The biomineralization mechanism occurring in natural
processes is widely attributed to the speciﬁc ability of amino
acids, peptide fragments and more complex biological entities,
to concentrate inorganic cations (for example Ca2þ and Zn2þ )
to seed biominerals9,35,36. In this case, we posit that MOF
biomimetic mineralization is facilitated by the biomacromolecules
afﬁnity towards the imidazole-containing building block arising
from intermolecular hydrogen bonding and hydrophobic
interactions37,38. 1H-NMR spectroscopy and ICP analysis
conﬁrmed that each BSA protein molecule accumulates B31
HmIm ligands and 22 Zn2þ ions, respectively (Fig. 2g and
Supplementary Fig. 8). Increasing the local concentration of both
metal cations and organic ligands would facilitate prenucleation
clusters of ZIF-8 around the biomacromolecules, and thus lead to
controlled crystal formation39. This hypothesis is further
conﬁrmed by in situ synchrotron SAXS experiments designed
to follow the MOF biomimetic mineralization process
(Supplementary Figs 9 and 10). Analysis of the X-ray scattering
reveals that small particles (radius of gyration, Rg¼ 35 nm) were
formed in small quantity in the aqueous solution immediately
after injection of the ZIF-8 precursors. In contrast, when BSA was
introduced into the solution, the rapid formation of a second
generation of larger particles (B30 s, Rg¼ 100 nm) and a
simultaneous depletion of the small particles were observed
(Supplementary Figs 9 and 10). Increasing the amount of BSA
added to the MOF precursor solution still facilitated the prompt
formation of particles (Supplementary Figs 11–14). After
separation and washing, samples of the crystalline product
analysed by PXRD revealed that increasing the amount of BSA
was enough to modify the ZIF-8 framework from a crystalline to
mostly amorphous morphology (Supplementary Fig. 13). This
further demonstrates that the described method mimics the
natural processes in which the degree of crystallinity is carefully
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Figure 2 | Characterization of biomimetically mineralized biocomposite. (a) SEM image showing the crystals obtained using BSA as a growth agent
for biomimetic mineralization (scale bar, 1 mm). (b) Photograph and (c) confocal laser scanning microscopy image of the biomomimetically mineralized
ZIF-8 composite obtained using BSA labelled with FITC. This biocomposite (ZIF-8/FITC-BSA) was prepared at 37 C, washed and exposed to ultraviolet
light of wavelength 365 and 495nm, respectively (scale bar, 10mm). (d) PXRD of the MOF-BSA biocomposite. (e) FTIR spectra of BSA (red), ZIF-8/BSA
(orange), standard ZIF-8 post incubated with BSA after washing (blue), and standard ZIF-8 (black). (f) SAXS data of the ZIF-8/BSA biocomposite
and a schematic showing the relative size of BSA to the mesopore. The observed Guinier knee can be ﬁtted using the Uniﬁed model58 with a radius
of gyration (Rg)
59 of 35 (± 5) Å, which is 17% larger than that of BSA 29.9Å (ref. 60). (g) Schematic proposing the biomimetically mineralized growth
of ZIF-8. Each BSA molecule attracts 31 2-methylimidazole (HmIm) ligands and 22 Zn2þ ions, facilitating the nucleation of ZIF-8 crystals39.
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tuned by living organisms due to complex biological
regulation8,40.
Extension of bimimetic mineralization to other MOFs.
Although we demonstrate biomimetically mineralized growth of
ZIF-8, other types of MOFs such as Cu3(BTC)2 (HKUST-1),
Eu2(1,4-BDC)3(H2O)4, Tb2(1,4-BDC)3(H2O)4 and Fe(III) dicar-
boxylate MOF (MIL-88A) can be successfully induced by BSA
(Supplementary Figs 15–19). FTIR performed before and after the
BSA-induced MOF coating shows that the amide vibrational
mode for the MOF/BSA composites is shifted towards higher
wavenumbers (Fig. 2e and Supplementary Fig. 20), indicating that
there is a protein–MOF interaction due to the coordination
between the Zn cations and the carbonyl group of the proteins41.
Biomimetic mineralization extended to enzymes and DNA.
We sought to explore the scope of biomimetically mineralized
MOF growth by using a series of biomacromolecules including
ovalbumin (OVA), ribonuclease A, human serum albumin (HSA),
pyrroloquinoline quinone-dependent glucose dehydrogenase
((PQQ)GDH), lipase, haemoglobin, lysozyme, insulin, horse-
radish peroxidase (HRP), trypsin, urease and oligonucleotide.
Notably, PXRD measurements (Fig. 3a) and nitrogen gas
adsorption isotherms (Supplementary Fig. 21) conﬁrm that ZIF-8
is present in its crystalline form and remains permanently porous.
Furthermore, SEM images show that the crystal morphology has
a unique dependence on the biomacromolecule (Fig. 3b–m). This
observation is analogous to natural biomineralization processes
where intricate crystalline morphologies are common6. Indeed, in
this work, nanoleaves, nanoﬂowers and nanostars are obtained by
using OVA, HRP and trypsin as biomimetic mineralization
agents and for single-strand DNA the typical rhombic ZIF-8
dodecahedron crystal morphology was observed.
Protective properties of biomimetically mineralized ZIF-8.
In nature, biomineral coatings are commonly used to protect
soft tissue from its surrounding environment. This knowledge
inspired us to examine whether MOF coatings could provide a
similar barrier that would enable embedded biomacromolecules
to withstand extreme conditions (for example, high temperature
and organic solvents) that would normally lead to decomposition.
Enhancing the robustness of functional biomacromolecules
would extend their potential for use in the pharmaceutical and
chemical synthesis sectors, addressing a major challenge in
biotechnology2,27,42.
Typically, exposing enzymes to elevated temperatures or
organic solvents results in an irreversible loss of bioactivity due
to the disruption of non-covalent interactions43. Thus, we
selected three well-studied enzymes (HRP, (PQQ)GDH and
urease, Supplementary Figs 22 and 23) and assessed whether a
MOF coating could enhance their stability to extreme conditions.
Accordingly, pyrogallol was added to a mixture of a ZIF-8/HRP
biocomposite and trypsin in phosphate buffer at pH 7.4.
Remarkably, in the presence of trypsin, the ZIF-8/HRP
biocomposite essentially retained the bioactivity of HRP
showing an 88% conversion of pyrogallol to purporogallin
(Fig. 4). This compares with only 20% conversion for an
analogous experiment where non-protected HRP was exposed
to trypsin. This experiment conﬁrms that the MOF coating acts as
a protective layer for the enzyme that allows diffusion of the
pyrogallol substrate (0.64 nm) through the ZIF-8 pore cavities
(1.16 nm) while preventing the egress of the proteolytic agent
trypsin. To benchmark the protective properties of the MOF
layers, we compared them to other, commonly employed, porous
protective coatings: CaCO3 and SiO2 with pores ranging from 7 to
100 nm (Supplementary Figs 24 and 25). We immersed free HRP,
CaCO3/HRP, SiO2/HRP and ZIF-8/HRP biocomposites in boiling
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Figure 3 | Characterization of biomimetically mineralized ZIF-8 with biomolecules. (a) PXRD patterns of the crystals obtained using various
biomacromolecules as biomimetic mineralizion agents. Protein encapsulation efﬁciency: BSA B100%, human serum albumin (HSA) B100%, OVA
B100%, lysozyme B96%, HRP B100%, ribonuclease A B86%, haemoglobin B90%, trypsin B96%, lipase B88%, insulin B86%, glucose
dehydrogenase (PQQ-GDH) B82%, urease B95%. In each case, the intensity and peak positions of the biocomposites match those of pure ZIF-8.
(b–m) Scanning electron microscopy images showing crystals obtained using: (b) OVA, (c) ribonuclease A, (d) HSA, (e) pyroloquinoline quinone-
dependent glucose dehydrogenase ((PQQ)GDH), (f) lipase, (g) haemoglobin, (h) lysozyme, (i) insulin, (j) HRP, (k) trypsin, (l) urease and
(m) oligonucleotide. Scale bars, 1 mm. While several biomacromolecules induce the standard rhombic dodecahedral morphology for the ZIF-8
biocomposites (c,d,m), other biomacromolecules gave rise to various morphological features such as truncated cubic (e,f,h,i,l), nanoleaf (b),
nanoﬂower (j) and nanostar (k), respectively.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8240
4 NATURE COMMUNICATIONS | 6:7240 | DOI: 10.1038/ncomms8240 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
water for 1 h (Fig. 4). As expected, the free enzyme completely
lost activity, while the CaCO3/HRP converted 39% and SiO2/HRP
composites converted 65% (7 nm pore), 44% (20 nm pore), 17%
(50 nm pore) and 13% (100 nm pore) of substrate, respectively.
These values are substantially less than the 88% conversion
achieved by the ZIF-8 protected HRP under the same
conditions. In a further set of experiments, the same systems
were immersed in boiling dimethylformamide for 1 h (Fig. 4).
Once again, the free enzyme completely lost activity, while
enzymes embedded in carbonate and silica particles showed 32
and 22% substrate conversion, respectively. Under these
conditions, the MOF biocomposites showed a 90% conversion
demonstrating again the unprecedented protective properties of
the MOF layers. PXRD measurements of the biocomposites
before and after the treatment in various harsh conditions showed
that the peak characteristics of ZIF-8 remained unchanged
(Supplementary Fig. 26), conﬁrming the stability of the MOF
biocomposites.
It has been reported that smaller pores engender higher
stability of the biomacromolecuels in denaturing conditions44.
We conﬁrm this trend in our experiments using silica
nanoparticles of varied pore sizes (Fig. 4). Therefore, the
superior stability afforded by the MOF protective layer
compared with CaCO3 and SiO2 can be directly related to the
tight encapsulation of each biomacromolecule by the MOF
structure. Indeed, each cavity within the MOF was found to range
from 17% (for BSA) to 30% (for urease) larger than the size of
their copying biomacromolecules as measured using SAXS
(Fig. 2f, Supplementary Fig. 27). In addition, FTIR experiments
of biomimetically mineralized ZIF-8 conﬁrmed the interaction
between the carbonyl groups of the protein backbone and the
Zn2þ cations of ZIF-8 (Supplementary Fig. 28). Indeed, bonding
interactions between enzymes and substrates are known to
improve the robustness of biomacromolecules45–47; accordingly,
these data point to a further contribution to the improved
stability of the MOF-encapsulated biomolecules. Enzymatic
activity studies performed on urease and (PQQ)GDH as a
biomimetic mineralization agent for the growth of ZIF-8 further
conﬁrmed improved stability over the corresponding free
enzymes (Supplementary Figs 22 and 23). For example, urease,
which denatures above 45 C (ref. 48), can be protected up to
80 C exemplifying a signiﬁcant relative improvement in the
enzyme stabilization. Because of the size of urease (B600 kDa)49
and its rapid degradation in presence of alcohols (for example,
methanol)50, the proposed biomimetic mineralizion process
overcomes the constraints of the previously reported methods
that aimed to use MOFs as hosts for biomacromolecules (that is,
biomolecules larger than MOF pores27–29 and/or the need for
organic solvents30).
Release of enzymes and proteins from ZIF-8 biocomposites.
While these MOF coatings display properties advantageous for
protecting enzymes in applications such as industrial catalysis
and environmental remediation, the ability to control the release
of bioactive macromolecules such as proteins, enzymes and DNA
is highly desired, as it would provide additional opportunities in
the areas of therapeutic delivery and genetic engineering10.
Indeed, as a class, biomacromolecules offer signiﬁcant advantages
over small molecules such as high speciﬁcity and potency10.
To this end, we demonstrate that the biomimetically mineralized
ZIF-8 layer can be removed via simple modulation of pH23
(Supplementary Fig. 29), and, importantly, that the liberated
biomacromolecule retains its native activity. To assess the effect
of pH on the protective layer, we employed ZIF-8/FITC-BSA
biocomposites. The pH-induced release proﬁles show that a
change from 7.4 to 6 is sufﬁcient to release the encapsulated
proteins (Supplementary Fig. 30).
To demonstrate that the activity of the occluded bio-
macromolecule is maintained after the protective shell is
removed, two separate biocomposites were prepared: a ZIF-8/
DQ-OVA (DQ-OVA is a ﬂuorogenic protein that shows high
ﬂorescence once proteolysis occurs) and ZIF-8/trypsin (trypsin is
a proteolytic enzyme). The two biocomposites were added to a
PBS solution at pH 7.4. The ﬂuorescent emission from this
solution was monitored and found to be analogous to that of free
intact DQ-OVA protein (Fig. 5a), thus indicating that the
biomacromolecules remain stable within the MOF. When the pH
of the solution was adjusted to 6.0, a drastic increase in the
ﬂuorescence intensity was observed which is attributed to the
proteolysis of the DQ-OVA into luminescent fragments;
suggesting that trypsin and DQ-OVA have been released from
their protective MOF coatings and are free to interact in solution
(Fig. 5b–e). This result conﬁrms that the bioactivity of both the
trypsin and the DQ-OVA is preserved following their release
from ZIF-8 and, along with the combined low toxicity of the
ZIF-8 coating23,33, supports the potential application of MOFs in
the area of biobanking or drug delivery.
Discussion
Here we have demonstrated the ﬁrst example of biomimetic
mineralization of MOFs. Furthermore, we show the presence of a
crucial synergistic interaction in the solution between the MOF
precursors and the biomacromolecules. This involves the bio-
macromolecule concentrating the MOF building blocks, which
leads to nucleation of porous crystals. In this process, the
biomacromolecules regulate the crystal size, morphology and
crystallinity while encapsulating itself within the porous crystal
and concomitantly generating new cavities that both tightly
surround the biomacromolecules and form bonding interactions
with the protein backbone. This mechanism is shown to protect a
variety of biomacromolecules (for example, proteins and
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Figure 4 | Protective performance of ZIF-8 coatings on HRP. Product
conversion of free HRP, the biomimetically mineralized ZIF-8 using HRP
(ZIF-8/HRP), HRP protected by calcium carbonate (CaCO3/HRP) and HRP
protected by mesoporous silica (SiO2/HRP, SiO2 with average pore size of
7, 20, 50 and 100 nm) in the presence of proteolytic agent, trypsin, after
treatment in boiling water for 1 h, and after treatment in boiling
dimethylformamide (DMF) for 1 h at 153 C, respectively. Data were
normalized against free HRP activity at room temperature. Error bars
represent the s.d. of three independent experiments.
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enzymes) from inhospitable environments. Enzymes encapsu-
lated in MOFs were shown to maintain their activity even after
the exposure to extreme conditions. This protective capacity is
remarkable, and far exceeds that of current materials used for this
purpose such as CaCO3 and mesoporous silica. The controlled
release of the biomacromolecules as a bioactive cargo from its
protective MOF coating can be achieved via simple pH
modiﬁcation. We anticipate that this bioinspired approach for
protecting and delivering functional biomacromolecules will
facilitate their application in areas where stability has previously
been an issue, such as industrial biocatalysis, biopharmaceuticals
and biobanking.
Methods
Materials. Cy3-labelled Oligonucleotide (50 bases, MW: 16 kDa) was purchased
from Trilink Biotechnologies Inc. (San Diego, California, USA). DQ-ovalbumin
(DQ-OVA) was obtained from Life Technologies (VIC, Australia). All other reac-
tants were purchased from Sigma-Aldrich and used without further modiﬁcation.
Biomimetic mineralization of ZIF-8/proteins. Various amounts of the appro-
priate proteins (e.g. 10, 50, 100, 200mg BSA) and enzymes (e.g. 80mg HRP) were
added into a solution of 2-methylimidazole (160mM, 20ml, pH 10.3) in deionized
water. (For insulin, 10mg insulin was added in water, the pH was adjusted to 3–4
with HCl (20mM) to completely dissolve the insulin and adjusted back to pH 10.3
before the addition of 2-methylimidazole (160mM)). A separate solution of zinc
acetate dihydrate dissolved in deionised water (40mM, 20ml) was also prepared.
These two solutions were combined and then agitated for 10 s. The resulting
solution was aged for 12 h at room temperature. The obtained precipitate was
recovered by centrifugation at 6,000 r.p.m. for 10min and then washed, sonicated,
and centrifuged twice each in water followed by ethanol. The encapsulation efﬁ-
ciency of proteins in ZIF-8 was determined by ﬂuorescent spectrophotometry using
a pre-determined calibration curve of FITC-labelled proteins. Protein encapsula-
tion efﬁciency: BSA B100%, HSA B100%, B100%, lysozyme B96%, HRP
B100%, ribonuclease AB86%, haemoglobinB90%, trypsinB96%, lipaseB88%,
insulin B86%, PQQ-GDH B82%, urease B95%.
Biomimetic mineralization of ZIF-8/DNA. Cy3-labelled oligonucleotide (200 ml;
20.8 mM) was added into a solution of 2-methylimidazole (160mM, 0.5ml) in
deionized water. A separate solution of zinc acetate dissolved in deionised water
(40mM, 0.5ml) was prepared. These two solutions were then mixed and vortexed
for 10 s. The mixture was aged for 12 h at room temperature. The obtained
precipitate was recovered by centrifugation at 6,000 r.p.m. for 10min and then
washed, sonicated, and centrifuged twice each in water followed by ethanol. The
encapsulation efﬁciency (75%) of the DNA in ZIF-8 was determined using a
ﬂuorescence spectrophotometer collecting the emission at 561 nm (Cy3 emission
maximum) from a pre-determined calibration curve, by measuring the con-
centrations of the DNA in the precursor solution and in the supernatant of the
obtained crystals.
Biomimetic mineralization of HKUST-1. Benzene-1,3,5-tricarboxylic acid (BTC)
was dissolved in ethanol (53.45mM, 20ml). A separate solution of copper(II)
nitrate dissolved in deionized water (40.09mM, 20ml) was also prepared. These
two solutions were then mixed and vortexed for 10 s. BSA solution (1.2ml;
10mgml 1 in MQ) was then added into the mixture. The mixture was aged for
12 h at room temperature. The suspension was centrifuged at 6,000 r.p.m. for
20min, and subjected to centrifugation–wash cycles three times using ethanol.
Biomimetic mineralization of Eu-BDC and Tb-BDC. Disodium terephthalate salt
was prepared following the procedure from the literature51. 5 g of terephthalic acid
(BDC) was dissolved in deionized water to which 2.32 g of sodium hydroxide was
added. The resulting solution was evaporated to dryness and the solid was then
resuspended in ethanol and reﬂuxed for 1 h before ﬁltering, washing with water and
drying. The disodium salt of terephthalic acid was then dissolved in deionized water
(10mM, 20ml) to which the 20mg of BSA was dissolved. The EuCl3.6H2O or
TbCl3.6H2O was also dissolved in deionized water (10mM, 20ml). The lanthanide salt
solution and the BSA ligand solution were then mixed and vortexed for 10 s. The
solution was gently agitated for 12 h before recovering the precipitate by centrifugation
at 6,000 r.p.m. for 20min and then washing and centrifuging in ethanol three times.
Biomimetic mineralization of MIL-88A. Various amount of BSA (2, 4, 8,
16mgml) was dissolved in fumaric acid solution in deionized water (25mM).
A separate solution of FeCl3  6H2O (25mM) was prepared and immediately mixed
with equal volumes of BSA-containing fumaric acid solution and vortexed for 10 s.
The solution mixture was aged for 7 days at room temperature. The suspension was
centrifuged at 6,000 r.p.m. for 20min, and subjected to centrifugation–wash cycles
three times using ethanol.
Bioactivity of ZIF-8/HRP. The obtained crystals were ﬁrstly redispersed in SDS
(0.2 g in 2ml deionized water) solution at 70 C for 10min to wash off the free
enzymes on the crystal surface52,53, followed by three centrifugation/wash cycles in
water. The activity of HRP (1.11.1.7; lot no. 125F-9640, HRPO Type U; Sigma
Chemical Co., St. Louis, MO) was determined by measuring the rate of
decomposition of hydrogen peroxide with pyrogallol as the hydrogen donor, which
can be converted to a yellowish product, purpurogallin54. In a typical assay,
solution A containing 76 ml KH2PO3 (100mM, pH 6.0), 38ml H2O2 (5% w/w in
deionized water), 76 ml pyrogallol (5% w/w in deionized water) and 1.8ml of PBS
buffer (pH 7.4) was prepared. To solution A, ZIF-8/HRP crystals were added, and
the absorbance of the solution was immediately monitored at 420 nm
using a UV-Vis spectrophotometer at 30 s increments. In an enzymatic activity
assay using free HRP, the amount of free enzymes introduced into solution A was
adjusted to be equal to the amount of enzymes loaded into ZIF-8/HRP, as
determined from the loading efﬁciency.
Bioactivity of ZIF-8/(PQQ)GDH. The obtained crystals were redispersed in a
SDS (10%w/w in deionised water, 2ml) solution at 70 C for 10min to wash off the
free enzymes on the crystal surface,52,53 followed by three centrifugation/wash
cycles in water. The activity of (PQQ)GDH was determined using phenazine
methosulfate as an electron acceptor55,56. In a typical assay, solution B containing
1ml glucose (20mM in 10mM MOPS buffer pH 7.0) 10 ml 2,6-dichloroindophenol
(0.1mM in deionized water), 10 ml phenazine methosulfate (0.06mM in deionised
water) was prepared. To solution B, ZIF-8/(PQQ)GDH crystals were added, and
the absorbance of the solution was immediately monitored at 600 nm using a
UV-Vis spectrophotometer at 30 s increments. In an enzymatic activity assay using
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Figure 5 | Controlled release of bioactive enzymes and proteins from
ZIF-8 biocomposites. (a) Fluorescent measurement of the PBS solution
containing biomimetically mineralized zeolitic imidazolate framework-
ﬂuorogenic protein (ZIF-8/DQ-OVA) and biomimetically mineralized
zeolitic imidazolate framework-trypsin (ZIF-8/trypsin) particles. At pH 7.4,
the ﬂuorescent emission (blue line) was analogous to that of free intact
DQ-OVA protein (brown line). At pH 6.0, a drastic increase in the
ﬂuorescence intensity (red line) was observed, which was attributed to the
proteolysis of the DQ-OVA into luminescent fragments suggesting that
trypsin and DQ-OVA have been released and are free to interact in solution.
(b–e) Schematics showing the release of DQ-OVA (red) and trypsin
(yellow) from ZIF-8 biocomposites at pH 6.0, and degradation of DQ-OVA
into ﬂuorescent fragments as a result of proteolysis by trypsin.
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free (PQQ)GDH, the amount of free enzymes introduced into solution B was
adjusted to be equal to the amount of enzymes loaded into ZIF-8/(PQQ)GDH, as
determined from the loading efﬁciency.
Bioactivity of ZIF-8/urease. The activity of ZIF-8/urease was determined by
measuring the pH increase as a result of urea conversion to ammonia, using phenol
red as a pH indicator57. Phenol red solution was prepared by dissolving 10mg
phenol red in 284 ml of NaOH solution (0.1M), and made up to a ﬁnal volume of
10ml with deionized water. In a typical assay, 10 ml phenol red solution, 990 ml urea
solution (0.5M) and ZIF-8/urease was added into an ultraviolet–visible cuvette,
and the absorbance of the solution was monitored at 560 nm using a UV-Vis
spectrophotometer at 30 s increments.
pH-triggered release of biomacromolecules. ZIF-8/FITC-BSA (1mg) was
dispersed in 2ml of pH-adjusted PBS at pH 7.4 or pH 6.0 at 37 C under gentle
agitation. Over 24 h, at regular time intervals, the crystal dispersion was centrifuged
at 6,000 r.p.m. for 20min, and the ﬂuorescence intensity of the released FITC-BSA
was assessed by monitoring the ﬂuorescent intensity from the supernatant using a
ﬂuorescence spectrophotometer.
Bioactivity from released enzymes. Equal volumes of colloidal solution
containing ZIF-8/trypsin and ZIF-8/DQ-OVA were added to 2ml pH-adjusted
PBS at pH 7.4 or pH 6.0 at 37 C under gentle agitation. The ﬂuorescent emission
at 515 nm from the BODIPY dye in the solution that resulted from the proteolysis
of DQ-OVA by trypsin was constantly monitored using a ﬂuorescence
spectrophotometer.
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